VivoSeq
Other

Pulmonary Function

0

Pipeline Programs

4

Active Trials

0

Companies Involved

Pulmonary Function is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

11/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

19

clinical trials

Completed8 · 42%
Unknown status5 · 26%
Recruiting2 · 11%
Not yet recruiting2 · 11%
Terminated2 · 11%

Trial Activity

19 trials

Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Recruiting··Phase 2·NCT01280994·445 enrolled
Hyperbaric on Pulmonary Functions in Post Covid -19 Patients.
Completed··N/A·NCT05977166·72 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)